Meeting
2012 Gastrointestinal Cancers Symposium
Effect of increased time from chemoradiation to surgery on the pathologic complete response rate in patients with esophageal cancer.
Authors
Talha Shaikh
Fox Chase Cancer Center, Philadelphia, PA
Talha Shaikh , Karen Ruth , Walter Joseph Scott , Barbara Burtness , Steven J. Cohen , Andre A. Konski , Harry S Cooper , Igor A. Astsaturov , Joshua E. Meyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 84)
DOI
10.1200/jco.2012.30.4_suppl.84
Abstract #
84
Poster Bd #
B42
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Expression molecular subtype as a predictor of outcomes of chemoradiotherapy for esophageal cancer.
First Author: Manabu Muto
Poster
2022 ASCO Annual Meeting
Preoperative chemoradiation (CRT) with carboplatin (CBP)/paclitaxel (PCL) (CP) or with 5-fluorouracil (FU)/oxaliplatin (OX) (Fx) for esophageal or junctional cancer: A randomized phase 2 trial.
First Author: Antoine Adenis
Poster
2020 Gastrointestinal Cancers Symposium
Phase II study of trifluridine/tipiracil (FTD/TPI) and oxaliplatin as induction chemotherapy (IC) in resectable esophageal and gastroesophageal junction adenocarcinoma (EGAC).
First Author: Sarbajit Mukherjee
Poster
2018 ASCO Annual Meeting
Survival outcomes from CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.
First Author: Karyn A. Goodman